A clinical genomics company built on whole-genome sequencing, interpreting cancer and rare-disease genomes for clinicians, patients, and researchers.
KAIST / Inocras
Released January 6, 2026
Masked DNA language model with a learnable, adaptive tokenizer that produces context-dependent, variable-length segments instead of fixed k-mers.